College student dies as reckless garbage truck hits her scooter

News Network
January 23, 2018

Bengaluru, Jan 23: A 24-year-old girl was killed after a speeding BBMP garbage truck struck her scooter and ran her over on the busy Race Course Road in Central Bengaluru on Monday.

The victim has been identified as B N Sahithya, of Rajajinagar, and a final year student of architecture at a college near Hesaraghatta Road. Her father Nagaraj runs a printing press. She was interning at the firm on Cunningham Road.

She was on the way to an architecture firm on Cunningham Road when the garbage truck rear-ended her Honda Activa near Raceview Hotel, close to Maurya Circle, around 11.20 am.

She fell off the scooter and screamed for help, but the garbage truck didn't stop. It dragged the scooter for almost 200 metres until the two-wheeler slammed into the road divider and screeched to a halt.

The accident has been caught on CCTV camera. The student was wearing a helmet but it was of little help. Passersby rushed her to a hospital but she died on the way. The truck driver just drove off. 

A senior police officer quoted an eyewitness as saying that the truck was driven in a rash manner and appeared to be heading towards the old High Grounds police station.

Police traced the driver's address and went to his house but didn't find him there. The officer said the suspect was possibly drunk at the wheel.

Comments

Mohammed
 - 
Tuesday, 23 Jan 2018

إِنَّا لِلّهِ وَإِنَّـا إِلَيْهِ رَاجِعونَ

Ibrahim
 - 
Tuesday, 23 Jan 2018

Inna lillahi wa inna ilayhi raji'un

Ajith
 - 
Tuesday, 23 Jan 2018

Very Sad :( may Her Soul Rest In Peace 

Kumar
 - 
Tuesday, 23 Jan 2018

Blame will be always on big vehicles. It might be girl's mistake

Danish
 - 
Tuesday, 23 Jan 2018

Speed thrill but kills

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 12,2020

Mangaluru, May 12: Two people hailing from Udupi district tested positive for covid-19 today. The sources of this infection is said to be Mangaluru's First Neuro Hospital.

Fresh bulletin from health and family welfare department revealed that a 52-year-old woman and a 26-year-old man from Karkala in Udupi were tested positive for the deadly coronavirus.

Among them, the woman had undergone treatment at the First Neuro Hospital. She is said to have contracted the infection from P-507 who was also was tested positive  April 27. And the youth was in touch with the woman.

The duo have not visited their home in Karkala for past few days. They were in quarantine and tested positive while being admitted at the same hospital.

With this the total number of COVID-19 cases found in Dakshina Kannada district are 33 now. Three among them have died and 14 have been discharged. Now, the district has 16 active coronavirus cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigst.com web desk
June 20,2020

New Delhi, Jun 20: As part of measures to check the spread of covid-19, Indian Railways is likely to stop distributing blankets and pillows in trains to AC passengers in coming days and it will make arrangements for sale at stalls on platforms.

The railways already stopped distributing blankets and pillows in 15 pair Special Rajdhani trains and 100 pair of fixed timetabled special trains, which is being operted at present. The system of not distributing blanks and pillows may continue in future once train operations normalise, said the official.

Passengers are encouraged to bring their own blankets and pillows. However same will be made available for purchase at shops so that if passengers want they can buy it, said an official.

The railways also made arrangements to sell sanitisers, masks and gloves at shops. The national transporter also said sale price should not exceed maximum retail price.

As per the Railway Board circular to zonal railways, " Amongst the items which fulfill the needs of travelling public and in keeping with the emphasis for providing safe and hygine travel facilities to passengers, it must be ensured that take away bedrolls kits/items other COVID-19 related protective items such as masks, sanitiser, gloves etc are also made available for sale through multi purpose stalls."

All items should be in good quality and will be sold only at MRP rate, circular said. The railways has also permanently removed curtains inside the AC coaches.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.